BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 5538813)

  • 1. The dilemma of vasopressors and vasodilators in the therapy of shock.
    Shoemaker WC; Brown RS
    Surg Gynecol Obstet; 1971 Jan; 132(1):51-7. PubMed ID: 5538813
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drugs in shock treatment].
    Dietzman RH; Motsay GJ; Lillehei RC
    Internist (Berl); 1971 Mar; 12(3):103-7. PubMed ID: 4927712
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of sympathomimetics and sympatholytics in shock].
    Torsti P
    Duodecim; 1971; 87(4):297-304. PubMed ID: 5547048
    [No Abstract]   [Full Text] [Related]  

  • 4. Indications for adrenergic stimulators in shock.
    Mills LC; Moyer JH
    Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):385-95. PubMed ID: 5566718
    [No Abstract]   [Full Text] [Related]  

  • 5. [Basic principles of the therapy of shock].
    Schröder R
    Minerva Med; 1972 Dec; 63(93):5243-6. PubMed ID: 4646406
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of vasoactive drugs in the treatment of shock.
    Berk JL
    Surg Clin North Am; 1975 Jun; 55(3):721-8. PubMed ID: 1135753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressor agents in shock.
    Moyer JH; Mills LC
    Am J Nurs; 1975 Apr; 75(4):620-5. PubMed ID: 1039254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current status of the treatment of infectious shock].
    Rapin M
    Anesth Analg (Paris); 1969; 26(5):753-62. PubMed ID: 5368578
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiogenic shock: a review.
    Perlroth MG; Harrison DC
    Clin Pharmacol Ther; 1969; 10(4):449-67. PubMed ID: 4893583
    [No Abstract]   [Full Text] [Related]  

  • 10. Vasopressors and other drugs used in shock.
    Br Med J; 1970 Sep; 3(5725):756-7. PubMed ID: 5472761
    [No Abstract]   [Full Text] [Related]  

  • 11. [Central venous pressure in control of cardiogenic shock].
    Gavrilescu S; Cotoi S; Riviş I
    Med Interna (Bucur); 1968 Nov; 20(11):1361-8. PubMed ID: 5731992
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of vasoactive agents in shock therapy.
    Ogburn P
    Vet Clin North Am; 1976 May; 6(2):287-95. PubMed ID: 775751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic spectrum of vasopressor and vasodilator drugs.
    Lewis CM; Weil MH
    JAMA; 1969 May; 208(8):1391-8. PubMed ID: 4307223
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic changes, treatment, and prognosis in clinical shock.
    Wilson RF; Sarver EJ; Rizzo J
    Arch Surg; 1971 Jan; 102(1):21-4. PubMed ID: 5538763
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic effects of sympathomimetic amines in clinical shock.
    Brown RS; Carey JS; Woodward NW; Mohr PA; Shoemaker WC
    Surg Gynecol Obstet; 1966 Feb; 122(2):303-7. PubMed ID: 5901296
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adrenergic receptor drugs in treatment of shock].
    Huguenard P
    Laval Med; 1971 Sep; 42(7):8638-40. PubMed ID: 4398770
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic assistance to the failing circulation.
    Clauss RH; Ray JF
    Surg Gynecol Obstet; 1968 Mar; 126(3):611-31. PubMed ID: 4295683
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of vasoactive drugs on oxygen consumption in endotoxin shock.
    Anas P; Hardy JD
    Arch Surg; 1969 Feb; 98(2):189-93. PubMed ID: 4885452
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemodynamic effects of isoproterenol and noradrenalin in experimental shock.
    Dedichen H; Schenk WG
    Acta Chir Scand; 1973; 139(3):213-8. PubMed ID: 4698482
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of severe shock with phenoxybenzamine.
    Hardaway RM
    Surg Gynecol Obstet; 1980 Dec; 151(6):725-34. PubMed ID: 7444723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.